Share Focus on Global Medicine
Share to email
Share to Facebook
Share to X
By ReachMD
The podcast currently has 88 episodes available.
With cases being reported in every state and across 80 countries, Lyme disease has become one of the fastest growing vector-borne illnesses in the world. But have you ever wondered how this global health threat came to be? That’s what journalist Mary Beth Pfeiffer investigates in her book, Lyme: The First Epidemic of Climate Change, and with the ReachMD team.
El cáncer colorrectal metastásico es difícil de tratar y presenta varias mutaciones genéticas, expresiones y amplificaciones, tal como la lateralidad del tumor. Y, tal como explican el Dr. Scott Kopetz, el Dr. Rui-Hua Xu y el Dr. Alberto Sobrero, aunque identificar estas distinciones puede resultar una tarea difícil, al hacerlo se averiguan pistas esenciales para decidir cuál es la mejor opción de tratamiento para cada paciente.
O cancro colorretal metastático é difícil de gerir e tem múltiplas mutações genéticas, expressões e amplificações, tais como o lado do tumor. E, apesar dos desafios em identificar estas distinções, estas também oferecem pistas essenciais sobre qual a melhor opção de tratamento para cada doente, tal como explicam o Dr. Scott Kopetz, o Dr. Rui-Hua Xu e o Dr. Alberto Sobrero.
Metastatic colorectal cancer is difficult to manage and has multiple genetic mutations, expressions, and amplifications, such as tumor sidedness. And while identifying these distinctions can be challenging, they offer essential clues to which treatment option is best for each patient, as Dr. Scott Kopetz, Dr. Rui-Hua Xu, and Dr. Alberto Sobrero explain.
Tuberculosis (TB) takes a life every 18 seconds…but you can play a part in putting a stop to the spread of this infectious disease by adopting screening best practices. Here to run down who and how you should screen for TB is Dr. Masae Kawamura, Qiagen’s Senior Director of Scientific and Medical Affairs.
To help us understand how primary care physicians can lead the way in proactively identifying and treating patients at high risk for TB, we caught up with Dr. Lee Reichman, Founding Executive Director of the Rutgers Global Tuberculosis Institute and Professor of Medicine and Epidemiology at Rutgers New Jersey Medical School.
Primary care physicians play a critical role in eliminating TB, which is why they need to know who they should screen for TB and how. Join Dr. Scott Lindquist, state epidemiologist for communicable diseases and Deputy Health Officer for Washington State, as he explains the importance of risk-based TB screening and the testing methods that are appropriate for these patients.
Beth Macy’s Dopesick is a heartbreaking trajectory that illustrates how America’s twenty-plus year struggle with opioid addiction has persisted for this long and has become so firmly entrenched in practically every corner of our country—from desolate cities to once idyllic farm towns.
Tune in as Beth Macy joins Dr. Maurice Pickard to illuminate the persistent and often conflicting gaps in the treatment and criminal-justice landscapes while shining a hopeful light on the heroes battling the worst drug epidemic in American history.
Rheumatology services are limited or non-existent in many parts of sub-Saharan Africa. Basic diagnostic tests, biological agents, and treatments are either unavailable or not affordable for the majority of people living in that area.
This shortage results in patients not having the benefit of early diagnosis and management of relatively cheap and cost-effective therapies. Instead, they present at advanced stages of disease with otherwise preventable morbidity.
Host Michael Greenberg chats with Dr. Michele Meltzer, Associate Professor at Jefferson University Hospitals in Philadelphia and President of the non-profit organization, Rheumatology for All, about providing medical training and care for countries with limited or non-existent rheumatology services.
The podcast currently has 88 episodes available.